is tirzepatide still allowed to be compounded FDA Says Must Exit the Market FDA ban on compounded tirzepatide:

Higher body weight can also make some MS symptoms (such as pain and bladder problems) more severe

The use of basket trials within the core registration program is novel in the cardiometabolic disease space and improves the efficiency and speed with which the impact of obesity treatment on multiple complications can be understood

Improved Metabolic Health: Beyond weight loss, semaglutide helps improve cholesterol levels, reduce blood pressure, and enhance overall metabolic health

Neither choice is wrong

Certain detrimental effects on a childs health are strongly correlated with maternal obesity and gestational diabetes underscoring the need for a safer and more efficient drug (89)